🇺🇸 FDA
Pipeline program

riliprubart

LTS16637

Phase 1 small_molecule active

Quick answer

riliprubart for Autoimmune haemolytic anaemia is a Phase 1 program (small_molecule) at Vera Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Vera Therapeutics
Indication
Autoimmune haemolytic anaemia
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials